Azacitidine Impurity 5-Azacytosine COA Quality Assurance
In the pharmaceutical industry, the integrity of active pharmaceutical ingredients (APIs) relies heavily on the rigorous control of related substances. 5-Azacytosine serves as a critical reference standard and potential degradation product within the Azacitidine supply chain. Understanding its regulatory context and quality metrics is essential for procurement teams managing oncology drug portfolios.
Regulatory Significance of 5-Azacytosine in Azacitidine Impurity Profiling
The presence of 5-Azacytosine, chemically known as 4-amino-1,3,5-triazin-2-one, is a primary concern during the stability testing of Azacitidine (CAS: 320-67-2). As a pyrimidine nucleoside analog used to treat myelodysplastic syndromes, Azacitidine must meet strict International Council for Harmonisation (ICH) guidelines regarding impurity thresholds. Regulatory bodies require that any Azacitidine Impurity exceeding identification thresholds be fully characterized to ensure patient safety and drug efficacy.
During the synthesis and storage of the API, hydrolytic degradation can occur, leading to the formation of the free base, 5-Azacytosine. This compound acts as a chemical building block in the original synthesis but becomes a liability if present in the final drug substance above specified limits. Procurement officers must verify that suppliers have robust methods to detect and quantify this specific impurity during batch release testing.
Furthermore, the regulatory significance extends to bioanalytical research where accurate quantification is vital for pharmacokinetic studies. Impurities can alter the perceived metabolic profile of the drug, leading to incorrect dosing conclusions. Therefore, maintaining a high level of purity in reference standards used for these assays is non-negotiable for compliance with FDA and EMA submissions.
Manufacturers must document the origin and control strategy for this impurity within their Drug Master Files (DMF). This includes detailing the synthesis route used to generate the API and identifying potential points where 5-Azacytosine could be introduced or formed. Comprehensive impurity profiling ensures that the final medicinal product remains stable throughout its shelf life.
Critical COA Quality Assurance Metrics for Azacitidine Impurity 5-Azacytosine
A Certificate of Analysis (COA) is the foundational document for quality assurance in chemical procurement. For 5-Azacytosine, the COA must provide transparent data regarding identity, purity, and physical properties. At NINGBO INNO PHARMCHEM CO.,LTD., we emphasize that a compliant COA goes beyond simple pass/fail results, offering detailed analytical conditions used during testing.
Key metrics on the COA should include the specific batch number, manufacturing date, and retest date. The document must explicitly state the molecular formula (C4H4N4O) and molecular weight (112.09 g/mol) to confirm identity. Additionally, the appearance description, such as off-white powder, helps logistics teams verify material integrity upon receipt without immediate laboratory testing.
| Metric | Specification | Importance |
|---|---|---|
| Purity (HPLC) | >98.0% | Ensures minimal interference in assays |
| Water Content | <0.5% | Prevents hydrolytic degradation |
| Residue on Ignition | <0.1% | Confirms inorganic impurity limits |
| Heavy Metals | <10 ppm | Compliance with safety standards |
Technical specifications must also cover residual solvents, adhering to ICH Q3C guidelines. Common solvents used during purification, such as methanol or ethanol, must be quantified to ensure they are within safe limits for handling and downstream processing. A comprehensive COA reduces the risk of supply chain disruptions caused by rejected materials during incoming quality control checks.
Reliable technical support from the supplier is crucial when interpreting COA data. If discrepancies arise between the certificate and internal testing results, the manufacturer must be able to provide raw chromatograms and spectral data for investigation. This level of transparency is a hallmark of a trusted global manufacturer committed to long-term partnerships.
Validating HPLC Purity and NMR Data for Compliance Verification
High-Performance Liquid Chromatography (HPLC) is the gold standard for determining the purity of 5-Azacytosine. A robust method should demonstrate resolution between the main peak and any related substances. High-quality batches often exhibit purity levels exceeding 99%, similar to the 99.69% benchmark seen in premium reference standards. This level of industrial purity is critical for accurate impurity profiling in Azacitidine drug substances.
For those interested in the production background, understanding the 5-Azacytosine Synthesis Route Industrial Purity Manufacturing Process provides insight into how potential by-products are minimized. Knowledge of the manufacturing process allows quality control teams to anticipate specific impurities that might appear in chromatograms, facilitating faster method development and validation.
Nuclear Magnetic Resonance (NMR) spectroscopy provides structural confirmation that HPLC cannot. Both 1H NMR and 13C NMR spectra must be consistent with the expected structure of 4-Amino-1H-[1,3,5]triazin-2-one. Discrepancies in chemical shifts can indicate the presence of isomers or salt forms that were not specified in the order. Validating this data ensures the material is suitable for use as a 5-Azacytosine reference standard.
Mass spectrometry (MS) data should also accompany the COA to confirm molecular weight and fragmentation patterns. This multi-technique approach ensures that the material is not only pure but also structurally identical to the pharmacopoeial standard. For research grade applications, having access to full spectral reports allows scientists to publish data with confidence, knowing the reference material is fully characterized.
Ensuring GMP Compliance in Azacitidine Impurity Storage and Batch Tracking
Proper storage conditions are vital to maintain the stability of 5-Azacytosine over time. The material should typically be stored as a powder in a cool, dry place, protected from light and moisture. If stored in solvent, specific temperature controls are required to prevent degradation. Adhering to these guidelines ensures that the impurity profile does not change before the material is used for testing.
Batch tracking systems must be robust enough to trace every gram of material from synthesis to delivery. This traceability is a core requirement of Good Manufacturing Practice (GMP) compliance. In the event of a recall or quality investigation, the ability to isolate specific batches prevents widespread disruption. For market analysis, understanding the 5-Azacytosine Bulk Price Global Manufacturer 2026 trends can help procurement teams plan long-term storage and purchasing strategies effectively.
Labeling must comply with global hazardous material regulations, clearly indicating the CAS number (931-86-2) and any safety warnings. Internal batch numbers should correlate directly with the COA provided. NINGBO INNO PHARMCHEM CO.,LTD. maintains rigorous documentation protocols to ensure that every shipment is accompanied by the correct regulatory paperwork, facilitating smooth customs clearance and internal auditing.
Regular stability testing of retained samples is another aspect of GMP compliance. Manufacturers should monitor stored batches periodically to confirm that purity levels remain within specification over the declared shelf life. This proactive approach minimizes the risk of using degraded materials in critical quality control assays, thereby protecting the integrity of the final pharmaceutical product.
Effective supply chain management for chemical intermediates requires a partnership built on transparency and technical excellence. By prioritizing detailed COAs, validated analytical data, and strict storage protocols, pharmaceutical companies can ensure their Azacitidine formulations meet all safety and efficacy requirements. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.